In First, Aging Stopped in Humans: TAU Co-Study

Written on |

New research finds that high pressure treatments can reverse two processes associated with aging and its illnesses

A first-of-its-kind clinical trial in human subjects: A new study from Tel Aviv University and the Shamir Medical Center indicates that HBOT (treatments with high-pressure oxygen) in healthy aging adults can stop the aging of blood cells.

The researchers found that a unique protocol of treatments in a pressure chamber can reverse two major processes associated with aging and its illnesses: the shortening of telomeres – protective regions located at both ends of every chromosome (the chromosomes contain the genetic material in the cell’s nucleus), and the accumulation of senescent (old and malfunctioning) cells in the body. Focusing on immune cells containing DNA, obtained from the participants’ blood, the study discovered a significant lengthening – up to 38% – of the telomeres, as well as a decrease of up to 37% in the presence of senescent cells.

The study was led by Prof. Shai Efrati, faculty member of the Sackler School of Medicine and the Sagol School of Neuroscience at Tel Aviv University and Founder and Director of the Sagol Center of Hyperbaric Medicine at the Shamir Medical Center, and Dr. Amir Hadanny, Chief Medical Research Officer of the Sagol Center for Hyperbaric Medicine and Research at the Shamir Medical Center. The clinical trial was conducted as part of a comprehensive Israeli research program that targets aging as a reversible disease. The paper was published in the scientific journal Aging in November 2020.

Prof. Efrati explains:  “For many years our team has been engaged in hyperbaric research and therapy – treatments based on protocols of exposure to high-pressure oxygen at various concentrations inside a pressure chamber. Our achievements over the years included the improvement of brain functions damaged by age, stroke or brain injury. In the current study we wished to examine the impact of HBOT on healthy and independent aging adults, and to discover whether such treatments can slow down, stop or even reverse the normal aging process at the cellular level.”

The researchers exposed 35 healthy individuals aged 64 or over to a series of 60 hyperbaric sessions over a period of 90 days. Each participant provided blood samples at four different points in time – before, during, at the end and after the series of treatments, and the researchers analyzed various immune cells (cells containing DNA) in the blood and compared the results.

The findings indicated that the treatments actually reversed the aging process in two of its major aspects: The telomeres at the ends of the chromosomes grew longer instead of shorter, at a rate of 20%-38% for the different cell types; and the percentage of senescent cells in the overall cell population was reduced significantly – by 11%-37% depending on cell type.

Prof. Efrati: “Today telomere shortening is considered the ‘Holy Grail’ of the biology of aging. Researchers around the world are trying to develop pharmacological and environmental interventions that enable telomere elongation.  Our HBOT protocol was able to achieve this, proving that the aging process can in fact be reversed at the basic cellular-molecular level.”

Dr. Hadanny: “Until now, interventions such as lifestyle modifications and intense exercise were shown to have some inhibiting effect on telomere shortening. But in our study, only three months of HBOT were able to elongate telomeres at rates far beyond any currently available interventions or lifestyle modifications. With this pioneering study, we have opened a door for further research on the cellular impact of HBOT and its potential for reversing the aging process.”

Related posts

Breakthrough Technology Could Lead to One-Time HIV Treatment

14 June 2022

TAU Researchers Find Gene Mechanism Linked to Autism and Alzheimer’s

26 May 2022

Want to Live Longer? Find Out if You Snore

15 May 2022

TAU Researchers Invent Healthy Weapon Against Covid

15 April 2022

Is the Vaccine Safe? Consult the Smart Sensor!

12 April 2022

TAU Nanodrug Enables 2-in-1 Attack on Cancer

6 April 2022

TAU Welcomes Ukrainian Emergency Fellowship Students

1 April 2022

Prof. Ehud Gazit – First Israeli to Receive Prestigious International Recognition in Chemistry

1 April 2022

Minor Head Injury Leads to Chronic Post-Concussion Syndrome in 1 of 4 Children

29 March 2022

Inventive Study to Develop Biological Solutions for Agriculture

28 March 2022

TAU Technology Could Prevent Repeat Heart Valve Surgery

25 March 2022

Israeli Breakthrough in Treating PTSD

22 February 2022

Discovery May Enable Early Diagnosis of Alzheimer’s

15 February 2022

TAU Breakthrough Offers New Hope to Help People With Paralysis Walk Again

8 February 2022

Ketogenic Diet Likely to Reduce Damage from Traumatic Brain Injuries

25 January 2022

Viruses and Game Theory

24 January 2022

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: office@aftau.asn.au

New South Wales

P.O. Box 4044, Maroubra South,
NSW 2035
Phone: +61 418 465 556
Email: davidsolomon@aftau.org.au

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: clivedonner@thelinqgroup.com